Clinical Trials List
Protocol NumberCJSB462B12201
Active
2025-05-01 - 2029-03-06
Phase II
Recruiting2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 黃意方 Division of Urology
- See-Tong Pang Division of Urology
- Yung-Chang Lin Division of Urology
- PO-HUNG LIN Division of Urology
- Jing-Ren Tseng Division of Urology
- Rita cheng Division of Urology
- I-hung Shao Division of Urology
- Kung-Chu Ho Division of Urology
- Hong-Cheng Gan Division of Urology
- 沈鼎文 Division of Urology
- Kai-Jie Yu Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
130 participants
